(By Balachander) Becton, Dickinson and Co. (NYSE:BDX) announced that its Chief Financial Officer David Elkins plans to resign, effective November and the medical technology company reaffirmed its earnings forecast for the full year.
The Franklin Lakes, New Jersey-based company named Suketu Upadhyay, its Senior Vice President and Controller, as interim CFO, effective November 9.
Elkins, who will leave BD in November following the company's 2012 results on November 7, has informed his intent to pursue an entrepreneurial opportunity at Round Rock Research, LLC, a technology licensing company.
Before joining BD in 2010, Upadhyay held senior-level finance positions with Johnson & Johnson (JNJ) and AstraZeneca (AZN).
Becton continues to project earnings per share from continuing operations in the range of $5.33 to $5.38 for 2012, while consensus estimate call in for the company to earn $5.36 a share.
The stock, which has been trading in the 52-week range of $70.05 to $80.56, closed Tuesday's regular trading at $77.23.